The Vasoreparative Function of Myeloid Angiogenic Cells Is Impaired in Diabetes Through the Induction of IL1β

Myeloid angiogenic cells (MACs) promote revascularization through the paracrine release of angiogenic factors and have been harnessed as therapeutic cells for many ischemic diseases. However, their proangiogenic properties have been suggested to be diminished in diabetes. This study investigates how...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Stem Cells
Prif Awduron: Chambers, Sarah E. J., O'Neill, Christina L., Guduric‐Fuchs, Jasenka, McLoughlin, Kiran J., Liew, Aaron, Egan, Aoife M., O'Brien, Timothy, Stitt, Alan W., Medina, Reinhold J.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: John Wiley and Sons Inc. 2018
Pynciau:
Regenerative Medicine
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6001623/
https://ncbi.nlm.nih.gov/pubmed/29484768
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/stem.2810
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg